FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence
Links shared publicly online about this topic.
- 868total visits
FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence
View full resource at news-medical.net
Most Recently Shared on September 17, 2010 at 4:54 am By:
FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence: Alkermes, Inc. today annou... http://bit.ly/aga8bQ
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL® For Opioid Dependence
medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-rele” View full resource at medicalnewstoday.com
Most Recently Shared on September 25, 2010 at 3:05 pm By:
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL® For Opioid Dependence http://mnt.to/3KmM #pain
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence...” View full resource at qualitypointtech.net
Most Recently Shared on September 19, 2010 at 2:01 pm By:
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence: Alkermes, Inc.... http://bit.ly/aQwbNM
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence
medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-rele” View full resource at medicalnewstoday.com
Most Recently Shared on September 19, 2010 at 1:05 pm By:
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence http://mnt.to/3JZ9 #alcohol #addiction
Pharma News: Alkermes, Arena - Forbes.com
forbes.com — “Alkermes (ALKS) said late yesterday that a FDA advisory committee voted 12 to 1 that its drug vivitrol should be approved to treat opioid dependence. The drug is currently approved to treat alcoholism.” View full resource at forbes.com
Most Recently Shared on September 17, 2010 at 6:39 pm By:
Pharma News: Alkermes, Arena: Alkermes (ALKS) said late yesterday that a FDA advisory committee voted 12 to 1... http://bit.ly/aTcjUv #drug
Alkermes Announces FDA Advisory Committee Recommends Approval of Vivitrol for Opioid Dependence - Drugs.com MedNews
drugs.com — “Sep 16, 2010 - Alkermes, Inc. (NASDAQ ALKS) today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted” View full resource at drugs.com
Most Recently Shared on September 17, 2010 at 1:14 pm By:
Alkermes Announces FDA Advisory Committee Recommends Approval of Vivitrol for Opioid Dependence: WALTHAM, Mas... http://bit.ly/awyaYT #drug
Advertisement

